GRAND RAPIDS ? Van Andel Institute has brought some world renowned scientists to West Michigan to honor the lifetime achievements of VAI Research Director George Vande Woude and this year?s Daniel Nathans Memorial Award co-recipients. More than 250 scientists from around the world are attending the Van Andel Institute?s 2006 scientific symposium, Winning the War
ANN ARBOR ? Pfizer has donated more than $4 million in surplus laboratory equipment to Ann Arbor SPARK and MichBio, which will lease the equipment to deserving Michigan technology start ups, with particular emphasis on life sciences companies. Pfizer, Michigan?s largest life-sciences company, donated more than 200 pieces of surplus research equipment to help get
ANN ARBOR ? Twelve MichBio member life sciences organizations won a total of $21.5 million from the first round of the 21st Century Jobs Fund. "We congratulate those of our members who are award recipients, ? said Stephen Rapundalo, Executive Director of MichBio. "These awards recognize the outstanding opportunities MichBio life sciences member organizations offer
ANN ARBOR - The 2006 MichBio Expo on Wednesday announced two of its keynote speakers for this year's conference to be held in Grand Rapids this October ? David Duncan, the co host of NPR's Biotech Nation, and David Van Andel, the CEO of the Van Andel Institute, a biomedical R&D center in Grand Rapids.
DETROIT ? Allied Minds, a pre-seed investment corporation specializing in early stage university business ventures, has partnered with Wayne State University to create GliaGen, which will specialize in novel diagnostic and therapeutic technologies specifically tailored to treat neurodegenerative diseases. GliaGen has exclusively secured platform technology developed by Drs. Leon Carlock and Maria Cypher at the
DETROIT ? Tissue bank Asterand is offering medical researchers the ability to obtain gene expression data through its new online gateway called Xpressway, the result of almost ten years of work by an Asterand team that specializes in human tissue-based research. Xpressway will help medical researchers understand which genes are expressed in different parts of
GRAND RAPIDS ? A New Jersey-based pharmaceutical R&D organization will spend $200,000 to partner with Michigan's Core Technology Alliance to develop four pilot projects in Michigan to help develop new drugs, the first out of state pharmaceutical company recruited by the former Michigan Life Sciences Corridor. Schering-Plough Research Institute, the research and development division of
ANN ARBOR ? University of Michigan technology spin out NanoBio Corp. will get a $30 million investment from Perseus, a private equity fund management company. The money will be used to support NanoBio's expanding clinical pipeline. NanoBio has developed multiple topical anti-infective products and vaccine candidates derived from its NanoStat technology. The company's lead product
LANSING ? MichBio, the state Life Sciences trade association, has been chosen to coordinate commercialization of life sciences products and services, assist start-up companies and develop marketing programs in hopes of giving the very young Michigan life sciences industry an economic shot in the arm. MichBio?s mandate under the 21st Century Jobs Fund Life Sciences
ANN ARBOR - QuatRx Pharmaceuticals Co. announced unexpectedly Monday that it has withdrawn its Initial Public Offering registration with the Securities and Exchange Commission because of poor market conditions. In a statement, QuatRx Chief Financial Officer Gary Onn said the market has not been kind to life science companies and QuatRx didn?t think it could